Effectiveness of adjuvant radiotherapy in patients with oropharyngeal and floor of mouth squamous cell carcinoma and concomitant histological verification of singular ipsilateral cervical lymph node metastasis (pN1-state)--a prospective multicenter randomized controlled clinical trial using a comprehensive cohort design

Maximilian Moergel, Antje Jahn-Eimermacher, Frank Krummenauer, Torsten E Reichert, Wilfried Wagner, Thomas G Wendt, Jochen A Werner, Bilal Al-Nawas, Maximilian Moergel, Antje Jahn-Eimermacher, Frank Krummenauer, Torsten E Reichert, Wilfried Wagner, Thomas G Wendt, Jochen A Werner, Bilal Al-Nawas

Abstract

Background: Modern radiotherapy plays an important role in therapy of advanced head and neck carcinomas. However, no clinical studies have been published addressing the effectiveness of postoperative radiotherapy in patients with small tumor (pT1, pT2) and concomitant ipsilateral metastasis of a single lymph node (pN1), which would provide a basis for a general treatment recommendation.

Methods/design: The present study is a non-blinded, prospective, multi-center randomized controlled trial (RCT). As the primary clinical endpoint, overall-survival in patients receiving postoperative radiation therapy vs. patients without adjuvant therapy following curative intended surgery is compared. The aim of the study is to enroll 560 adult males and females for 1:1 randomization to one of the two treatment arms (irradiation/no irradiation). Since patients with small tumor (T1/T2) but singular lymph node metastasis are rare and the amount of patients consenting to randomization is not predictable in advance, all patients rejecting randomization will be treated as preferred and enrolled in a prospective observational study (comprehensive cohort design) after giving informed consent. This observational part of the trial will be performed with maximum consistency to the treatment and observation protocol of the RCT. Because the impact of patient preference for a certain treatment option is not calculable, parallel design of RCT and observational study may provide a maximum of evidence and efficacy for evaluation of treatment outcome. Secondary clinical endpoints are as follows: incidence and time to tumor relapse (locoregional relapse, lymph node involvement and distant metastatic spread), Quality of life as reported by EORTC (QLQ-C30 with H&N 35 module), and time from operation to orofacial rehabilitation. All tumors represent a homogeneous clinical state and therefore additional investigation of protein expression levels within resection specimen may serve for establishment of surrogate parameters of patient outcome.

Conclusion: The inherent challenges of a rare clinical condition (pN1) and two substantially different therapy arms would limit the practicality of a classical randomized study. The concept of a Comprehensive Cohort Design combines the preference of a randomized study, with the option of careful data interpretation within an observational study.

Trial registration: ClinicalTrials.gov: NCT00964977.

Figures

Figure 1
Figure 1
According to Bier (1982) description of tumor position follows its relation to the occlusal plane, canine and the last molar in transversal, saggital and axial projection.
Figure 2
Figure 2
Definition of the cervival levels as defined by Robbins 1991.

References

    1. Parkin DM, Pisani P, Ferlay J. Global cancer statistics. CA Cancer J Clin. 1999;49:33–64. doi: 10.3322/canjclin.49.1.33.
    1. Pisani P, Parkin DM, Bray F, Ferlay J. Estimates of the worldwide mortality from 25 cancers in 1990. Int J Cancer. 1999;83:18–29. doi: 10.1002/(SICI)1097-0215(19990924)83:1<18::AID-IJC5>;2-M.
    1. Becker N, Warendorf J. Atlas of Cancer Mortality in the Federal Republic of Germany 1981-1990. 3. Berlin: Springer; 1997.
    1. Hoffmann H, Karnell L, Funk G, Robinson R, Menck H. The national cancer data base report on cancer of the head and neck. Arch Otolaryngol Head Neck Surg. 1998;124:951–962.
    1. Howaldt HP, Kainz M, Euler B, Vorast H. Proposal for modification of the TNM staging classification for cancer of the oral cavity. DOSAK. J Craniomaxillofac Surg. 1999;27:275–88.
    1. Mohr C, Bohndorf W, Carstens J, Harle F, Hausamen J, Hirche H, Kimmig H, Kutzner J, Muhlig J, Reuther J. Preoperative radiochemotherapy and radical surgery in comparison with radical surgery alone. A prospective, multicentric, randomised DÖSAK study of advanced squamous cell carcinoma of the oral cavity and the oropharynx (a 3-year follow-up) Int J Oral Maxillofac Surg. 1994;23:140–148. doi: 10.1016/S0901-5027(05)80288-7.
    1. Cooper JS, Pajak TF TF, Forastiere AA, Jacobs J, Campbell BH, Saxman SB, Kish JA, Kim HE, Cmelak AJ, Rotman M, Machtay M, Ensley JF, Chao KS, Schultz CJ, Lee N, Fu KK. Radiation Therapy Oncology Group 9501/Intergroup. Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck. N Engl J Med. 2004;350:1937–44. doi: 10.1056/NEJMoa032646.
    1. Vikram B, Strong EW, Shah JP, Spiro R. Failure in the neck following multimodality treatment for advanced head and neck cancer. Head Neck Surg. 1984;6:724–9. doi: 10.1002/hed.2890060304.
    1. Lundahl R, Foote R, Bonner J, Suman V, Lewis J, Kasperbauer J, McCaffrey T, Olsen K. Combined neck dissection and postoperative radiation therapy in the management of high risk neck: a matched-pair analysis. Int J Rad Oncol Biol Phys. 1998;40:529–534.
    1. Robbins K, Clayman G, Levine P, Medina J, Sessions R, Shaha A, Som P, Wolf G. Neck dissection classification update: revisions proposed by the American Head and Neck Society and the American Academy of Otolaryngology-Head and Neck Surgery. Arch Otolaryngol Head Neck Surg. 2002;7:751–758.
    1. H0022. Radiation Therapy Oncology Group Rtog 0022 Phase I/Ii Study Of Conformal And Intensity Modulated Irradiation For Oropharyngeal Cancer.
    1. Bier J. Definition zum radikalchirurgischen Vorgehen bei Plattenepithelkarzinomen der Mundhöhle. Dtsch Z. Mund-Kiefer-Gesichts-Chir. 1982;6:369–372.
    1. Schmoor C, Olschewski M, Schumacher M. Randomized and non-randomized patients in clinical trials: experiences with comprehensive cohort studies. Stat Med. 1996;15:263–71. doi: 10.1002/(SICI)1097-0258(19960215)15:3<263::AID-SIM165>;2-K.
    1. Concato J, Shah N, Horwitz RI. Randomized, controlled trials, observational studies, and the hierarchy of research designs. N Engl J Med. 2000;342:1887–92. doi: 10.1056/NEJM200006223422507.
    1. Millat B, Borie F, Fingerhut A. Patient's preference and randomization: new paradigm of evidence-based clinical research. World J Surg. 2005;29:596–600. doi: 10.1007/s00268-005-7920-z.
    1. Solomon MJ, McLeod RS. Should we be performing more randomized controlled trials evaluating surgical operations? Surgery. 1995;118:459–67. doi: 10.1016/S0039-6060(05)80359-9.
    1. McLeod RS, Wright JG, Solomon MJ, Hu X, Walters BC, Lossing A. Randomized controlled trials in surgery: Issues and problems. Surgery. 1996;119:483–6. doi: 10.1016/S0039-6060(96)80254-6.
    1. Rauschecker HF. [Introduction of studies by the German Breast Center Study Group (GBSG)] Zentralbl Chir. 1998;123(Suppl 5):25–7.
    1. Rauschecker HF, Sauerbrei W, Gatzemeier W, Sauer R, Schauer A, Schmoor C, Schumacher M. Eight-year results of a prospective non-randomised study on therapy of small breast cancer. The German Breast Cancer Study Group (GBSG) Eur J Cancer. 1998;34:315–23. doi: 10.1016/S0959-8049(97)10035-1.
    1. Paradis C. Bias in surgical research. Ann Surg. 2008;248:180–188. doi: 10.1097/SLA.0b013e318176bf4b.
    1. Andry G, Hamoir M, Leemans CR. The evolving role of surgery in the management of head and neck tumors. Curr Opin Oncol. 2005;17:241–248. doi: 10.1097/01.cco.0000160277.86386.dc.
    1. Schiff BA, Roberts DB, El-Naggar A, Garden AS, JN M. Selective vs modified radical neck dissection and postoperative radiotherapy vs observation in the treatment of squamous cell carcinoma of the oral tongue. Arch Otolaryngol Head Neck Surg. 2005;131:874–878. doi: 10.1001/archotol.131.10.874.

Source: PubMed

스폰서 및 공동 작업자

건강 상태

약물 개입

3
구독하다